162 related articles for article (PubMed ID: 10468134)
1. Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain.
Dunn AC; Walmsley RS; Dedrick RL; Wakefield AJ; Lockwood CM
J Infect; 1999 Jul; 39(1):81-7. PubMed ID: 10468134
[TBL] [Abstract][Full Text] [Related]
2. Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.
Schultz H; Csernok E; Johnston TW; Lockwood CM; Gross WL
J Immunol Methods; 1997 Jul; 205(2):127-33. PubMed ID: 9294593
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
Schultz H; Csernok E; Schuster A; Schmitz TS; Ernst M; Gross WL
Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
Schinke S; Fellermann K; Herlyn K; Reichel PH; Fundke R; Stange EF; Gross WL; Schultz H
Inflamm Bowel Dis; 2004 Nov; 10(6):763-70. PubMed ID: 15626895
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis.
Zhao MH; Jones SJ; Lockwood CM
Clin Exp Immunol; 1995 Jan; 99(1):49-56. PubMed ID: 7813109
[TBL] [Abstract][Full Text] [Related]
6. Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease.
Yang JJ; Tuttle R; Falk RJ; Jennette JC
Clin Exp Immunol; 1996 Jul; 105(1):125-31. PubMed ID: 8697620
[TBL] [Abstract][Full Text] [Related]
7. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
[TBL] [Abstract][Full Text] [Related]
8. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Vecchi M; Sinico A; Bianchi MB; Radice A; Gionchetti P; Campieri M; de Franchis R
Scand J Gastroenterol; 1998 Dec; 33(12):1284-8. PubMed ID: 9930392
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.
Stoffel MP; Csernok E; Herzberg C; Johnson T; Carroll SF; Gross WL
Clin Exp Immunol; 1996 Apr; 104(1):54-9. PubMed ID: 8603534
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
Zhao MH; Jayne DR; Ardiles LG; Culley F; Hodson ME; Lockwood CM
QJM; 1996 Apr; 89(4):259-65. PubMed ID: 8733512
[TBL] [Abstract][Full Text] [Related]
12. BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule.
Schultz H; Csernok E; Nikkari S; Toivanen P; Toivanen A; Gross WL
Scand J Rheumatol; 2000; 29(4):226-31. PubMed ID: 11028843
[TBL] [Abstract][Full Text] [Related]
13. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
15. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.
Cooper T; Savige J; Nassis L; Paspaliaris B; Neeson P; Neil J; Knight KR; Daskalakis M; Doery JC
Rheumatol Int; 2000; 19(4):129-36. PubMed ID: 10836522
[TBL] [Abstract][Full Text] [Related]
16. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
17. Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA.
White ML; Ma JK; Birr CA; Trown PW; Carroll SF
J Immunol Methods; 1994 Jan; 167(1-2):227-35. PubMed ID: 7508478
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
[TBL] [Abstract][Full Text] [Related]
19. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement.
Wada Y; Kuroda T; Murasawa A; Nakano M; Narita I
Mod Rheumatol; 2010 Jun; 20(3):252-6. PubMed ID: 20107854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]